| CAS NO: | 25406-64-8 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Morroniside has neuroprotective effect by inhibiting neuronapoptosisand MMP2/9 expression. | ||||||||||||||||
| IC50& Target[1] |
| ||||||||||||||||
| 体内研究 (In Vivo) | Morroniside reduces the expression of MMP2 and MMP9 in an I/R injury model. Treatment with Morroniside significantly reduces I/R-associated neuron apoptosis in a dose dependent manner. The results demonstrate that active caspase-3 and Bax are significantly upregulated in the model group compared with the control group, while Bcl-2 is significantly downregulated. The expression of active caspase-3 and Bax is significantly downregulated by Morroniside treatment in a dose-dependent manner, while the expression of Bcl-2 is significantly upregulated[1]. Morroniside has an ameliorative effect on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice[2]. | ||||||||||||||||
| 分子量 | 406.38 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C17H26O11 | ||||||||||||||||
| CAS 号 | 25406-64-8 | ||||||||||||||||
| 中文名称 | 莫诺苷 | ||||||||||||||||
| 结构分类 |
| ||||||||||||||||
| 来源 |
| ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 100 mg/mL(246.08 mM;Need ultrasonic) H2O : 50 mg/mL(123.04 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
